Breast cancer, vaccine

A clinical trial at WashU Medicine shows promising results for a personalized vaccine designed to prevent recurrence in ...
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...
Neoantigen DNA vaccines are safe and capable of inducing neoantigen-specific immune responses in patients with ...
A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.
Despite the positive outcome, the seasoned infectious disease researcher, faced multiple challenges when seeking to publish ...
Anixa Biosciences ( (ANIX) ) has provided an announcement. Anixa Biosciences, in collaboration with Cleveland Clinic, unveiled promising ...